Negative symptoms in schizophrenia: a target for new drug development.

H. Y. Meltzer*, J. Zureick

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)68-77
Number of pages10
JournalPsychopharmacology series
Volume7
DOIs
StatePublished - 1989

ASJC Scopus subject areas

  • Medicine(all)

Cite this